Tarsus Pharmaceuticals, Inc. (TARS)

NASDAQ: TARS · Real-Time Price · USD

78.23

-1.72 (-2.15%)

At close: Sep 15, 2026, 4:00 PM EDT

79.36

+1.13 (1.44%)

After-hours: Sep 15, 2026, 6:37 PM EDT

Tarsus Pharmaceuticals Financials Overview

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	606.33	451.36	182.95	17.45	25.82	57.03
Revenue Growth	105.17%	146.71%	948.62%	-32.42%	-54.73%	-
Gross Profit	501.26	356.35	116.74	-34.46	-17.76	13.24
Operating Income	-48.54	-70.97	-120.57	-143.16	-62.71	-12.16
Net Income	-46.48	-66.42	-115.55	-135.89	-62.09	-13.83
Earnings Per Share	-1.08	-1.59	-3.07	-4.62	-2.52	-0.67
EPS Growth	-	-	-	-	-	-

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	449.69	417.27	291.38	227.44	217.03	171.82
Total Debt	88.81	83.04	72.45	30.22	20.16	1.19
Net Cash (Debt)	360.88	334.23	218.92	197.23	196.87	170.62
Net Cash Growth	16.90%	52.67%	11.00%	0.18%	15.38%	1.99%
Net Cash Per Share	8.40	8.00	5.82	6.71	8.00	8.30

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	74.16	-12.45	-83.03	-117.49	-49.03	3.75
Capital Expenditures	-18.16	-9.86	-1.57	-1.5	-0.51	-0.59
Free Cash Flow	56	-22.31	-84.59	-119	-49.54	3.16
Free Cash Flow Growth	-	-	-	-	-	-

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	82.67%	78.95%	63.81%	-197.50%	-68.81%	23.22%
Operating Margin	-8.00%	-15.72%	-65.90%	-820.53%	-242.92%	-21.32%
Pretax Margin	-6.49%	-14.26%	-63.16%	-778.89%	-240.53%	-24.15%
Profit Margin	-7.66%	-14.71%	-63.16%	-778.89%	-240.51%	-24.25%
FCF Margin	9.24%	-4.94%	-46.24%	-682.04%	-191.88%	5.54%

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 16, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Forward PE	-	97.48	-	-	-	-
P/FCF Ratio	61.30	-	-	-	-	147.13
PS Ratio	5.66	7.70	11.57	38.42	15.15	8.16